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1. Introduction 
The binding sites for benzodiazepine tranquillising 
drugs in brain membranes are known to interact with 
a separate set of binding sites for y-aminobutyric acid 
(GABA). Evidence for this is both pharmacological 
[l-3] and from binding studies [4-lo] which show 
that GABA and certain GABA agonists enhance the 
binding of benzodiazepines. Support for the idea that 
the two sites are directly associated in one component 
or tightly-bound complex has come from the con- 
stancy of this linked binding in the brain at all ages 
from embryo to adult [ 111; furthermore, either 
GABAergic or benzodiazepine ligands protect, at dis- 
dinct sites, both types of binding from heat inactiva- 
tion [9,10]. 
On solubilisation of the benzodiazepine-binding 
component [12], it has been found that one set of 
GABA-binding sites is present with it (L.-R. C., 
E. A. B., unpublished). However, this could arise from 
association in the detergent media needed, and does 
not prove that they are in one complex in the mem- 
brane. We have now addressed this problem by pro- 
gressive inactivation of binding sites by electron bom- 
bardment of brain membranes, which can determine 
in a quantitative manner whether different sites are 
on the same molecular target. We also determine thus 
the size of the macromolecular structure in the mem- 
brane which carries these two types of binding site. 
2. Materials and methods 
Cerebral cortex was removed from 2-year-old 
cattle 10 min after slaughter, frozen on solid CO2 and 
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stored at -80°C. It was thawed, homogenised and the 
Pz (lysed synaptic membrane) fraction was prepared 
as in [ 121. This pellet was frozen at -2O”C, thawed 
and homogenised in 32 vol. 0.05 M Tris-citrate buffer 
(pH 7.1)/0.05% Triton X-100 [13] and held at 20°C 
for 30 min. After centrifugation (48 000 X g, 4”C, 
20 min) the pellet was washed 3 times with 32 vol. 
Tris-citrate buffer without Triton and once with dis- 
tilled water, each time with homogenisation and cen- 
trifugation as before. These treatments remove all 
endogeneous GABA and hence rnaximise [13] spe- 
cific, high-affinity [ 3H]muscimol binding. Another 
sample was prepared similarly but using 0.01% Triton 
X-100 at 4°C in place of 0.05% Triton at 2O”C, and 
then freeze-thawed and given an additional wash in 
the Tris-citrate buffer; this gave no difference in the 
&-values or irradiation behaviour to the first set of 
samples.Hence, the effects founddo not dependupon 
a particular detergent treatment. Protease inhibitors 
[12] were present at all stages up to, but not beyond, 
the final wash. 
The washed pellet in each case was re-homogenised 
in distilled water containing two enzyme markers (see 
below); aliquots were lyophilised in thick-wall Pyrex 
tubes and sealed in vacua. These were irradiated in the 
Cambridge linear accelerator [ 141; after various 
(metered) incident radiation doses at 20-3O”C, the 
vacuum was broken and the membranes re-homoge- 
nised at 4°C in Tris-citrate buffer. Appropriate ali- 
quots were taken in duplicate from each sample for 
measuring binding of each ligand, for assay of each 
enzyme marker and for protein determination. Bind- 
ing assays used [N-methyl-3H]flunitrazepam (75 Ci/ 
mmol) or [methylamine-3H]muscimol (9.5 Ci/mmol), 
both from the Radiochemical Centre [I]. In the standard 
assays 40 nM [jH]flunitrazepam or 50 nM [3H]mus- 
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cimol was used to follow the binding loss at the high 
affinity sites. Scatchard plots [ 121 of a range of binding 
data for the non-irradiated and the partly-inactivated 
membranes confirmed that those fixed concentrations 
represented saturation of binding to one class of high- 
affinity sites. In all assays non-specific binding was 
subtracted, using controls with I PM clonazepam or 
100 PM GABA, respectively, added. The specific bind- 
ing was always expressed per mg protein as measured 
in the same sample, to correct for any variation 
between membrane samples. 
The internal enzyme markers were alcohol dehy- 
drogenase (ADH) from yeast (2 units/tube) and E&K- 
richia co& ,&galactosidase (25 units/tube), the purest 
grades from Sigma. Other methods were as in [ 121. 
3. Results 
The binding of [ 3H]flunitrazepam to bovine cere- 
bral cortex membranes (prepared in the presence of 
protease inhibitors~, after freeze-thawing and exten- 
sive washing (see section 2), when represented as a 
Scatchard plot as for rat cortex 1121, showed a single 
class of binding sites, with K, = 5.5 nM and saturation 
binding of 1.3 pmoljmg protein. These values are of 
the same order as found for rat cortex [ 121 and agree 
with a report [9] for bovine cortex. The binding of 
muscimol has been shown [ 13,15,16] to correspond 
to GABA binding to its synaptic receptor sites, and 
was used here to show the latter. Freeze-thawed, 
thoroughly-washed membranes (see section 2) were 
used to remove endogenous inhibitors, including 
GABA [8,17]. When [3H]muscimol was used, similar 
binding analysis showed that up to 50 nM ligand the 
binding could be represented by one set of high-affin- 
ity sites, binding at their saturation 1.2 pmol/mg pro- 
tein with Kd = 5.8 nM. This, also, agrees fairly well 
with the report [9] on bovine brain membranes (pre- 
pared differently), These bindings were abolished by 
the presence of unlabelled clonazepam (1 O-6 M) or 
GABA (low4 M), respectively; i.e., they are specific. 
When the membranes were rapidly frozen in liquid 
Nz and freeze-dried, no loss of binding of either ligand 
occurred, the same binding parameters being obtained 
upon re-hydration. Samples of these membranes were 
irradiated to various total dosages and the decline in 
the numbers of binding sites present was followed 
(fig.1). It was clearly seen that the rate of loss of the 
benzodiazepine binding sites was equai to that of the 
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Fig.1. Radiation dosedependence of [ 3H]flunitrazepam bind- 
ing (o) and of highaffinity [ 3H]muscimol binding (0) in a 
given sample of bovine cortex membranes. (Where the two 
values coincided, half-shading is shown.) Also shown (0) is 
the enzymic activity of yeast alcohol dehydrogenase (ADH) 
irradiated in the same specimen, as one of the molecular mass 
markers. A/A, is the activity (binding or cnzymic) as a frac- 
tion of the initial activity (i.e., 1 .O at 0 Mrad), on a loga- 
rithmic scale. The lines were fitted by least squares. The slope 
of the binding activity plot (the dose-dependence) divided by 
the slope of the ADH plot is the inactivation ratio for ADH 
as the reference, as used in table 1. The steeper the dose- 
dependence slope, the larger the target molecular size. 
muscimol binding sites. Repeats of these experiments 
on 3 other brain cortex samples gave in every case an 
identical plot for the two properties. Binding of these 
ligands elsewhere (i .e ., non-specific) decayed much 
more slowly than the specific binding of each, and 
the bindings of other types of ligand to these mem- 
branes also showed quite different dose-dependences 
(unpublished). It is noteworthy that both types of 
specific binding site here lose activity in a single expo- 
nential process, in line with the single class of each 
identified with the Leigh-af~nity binding. 
By wellestablished target theory, the actual dose- 
dependence is related to the molecular size of the tar- 
get unit required for maintaining the activity in ques- 
tion (review [IS]). We have used the rate of loss of 
the binding site relative to that of enzymes of known 
size irradiated in the same sample, as the most accu- 
rate measure of the target size, avoiding other assump- 
tions which may not apply to proteins in biological 
membranes. Using yeast alcohol dehydrog~nasc 
(M, 149 000) and I?. coli P-galactosidase (M, 464 000 
[ 191) as these standards, their inactivation dose-depen- 
dence, refative to that of the benzodiazepine binding 
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Table 1 
Molecular masses of targets for radiation inactivation of specific binding sites 
Binding site Kd Reference 
(nWa proteinb 
Inac~n Molecular massC 
ratio 
[ ‘H] Flunitrazepam 5 5 PGalactosidase 0.542 
Yeast ADH 1.25 216 000 * 2500 
[ “HjMuscimol 5.8 PCalactosidase 0.547 
Yeast ADH 1.25 
217 000 + 1900 
a Dissociation constant of the sites monitored. This did not change significantly 
during the treatments 
b The reference enzyme named was irradiated in the same specimens, and its dose- 
dependence (the slope of a plot as in fig.1) was measured. The ratio of the dose- 
dependence for the ligand binding site inactivation to the reference dosedepen- 
dence is the inactivation ratio 
’ A linear calibration plot was employed, which relates the molecular masses of 6 
irradiated standard proteins to their inactivation ratios based upon either of the 
two reference proteins used here. (Full details of the calibration method will be 
presented elsewhere.) The inactivation ratio in each case here was converted 
thus to the corresponding target molecular weight. This is given as the mean 
(+SEM) for 4 expt of the type illustrated in fig.1 
(fig.1) during the same irradiation, yielded by com- 
parison a value for the functional size required to 
maintain the binding site (table 1). In all of the exper- 
iments this was the same as the value obtained in the 
case of the muscimol binding site (table l), confirming 
the behaviour illustrated in fig.1. 
4. Discussion 
To progressively destroy the two types of site-ben- 
zodiazepine-binding and GABA-binding - by electron 
bombardment is a procedure analogous to comparing 
their thermal inactivations. However, it differs in that 
with the irradiation a discrete packet of energy is 
applied which will destroy totally the target molecule 
if it impinges on it, and hence the parameter of the 
dose-dependence of the radiation effect offers a quan- 
titative and more sensitive test for the identity of two 
targets. By this test they are identical in the mem- 
brane. Of course, this could arise by a coincidence in 
the size of two different macromolecules. The latter 
appears to be a very improbable explanation in the 
present case, in the light of all of the other types of 
evidence (see section 1) that one site modulates bind- 
ing at the other. 
The other important advantage of the radiation 
method is that it ,unlike thermal inactivation, can actu- 
ally measure that target size. We obtain a value of 
2 17 000 Mr for the weight of the component which 
carries both types of site. This may be either one pro- 
tein ,or a complex if its component proteins are tightly 
enough bound together in ther membrane to serve as 
one functional unit, which is the significance of the 
target size. When solubihsed in detergent [12], a sedi- 
mentation coefficient of -9.5 S in sucrose density gra- 
dient centrifugation has been found in this laboratory 
for both the muscimol-binding component and the 
associated flunitrazepam-binding component (L.-R. C ., 
E. A. B. unpublished). Considerable inaccuracy is pos- 
sible in relating the sedimentation coefficient of a 
membrane protein in aqueous detergent solution to 
its molecular mass [20]: depending upon the amount 
of bound detergent and the degree of molecular asym- 
metry, the 9.5 S value could be due to a molecular 
complex of 2 17 000 M,, but further analysis would 
be needed to establish the true molecular mass in the 
solubilised form. 
There are several classes of GABA-binding site in 
brain membranes, but in the cerebral cortex musci- 
mol has been found to bind with high affinity 
(Kd < 10 nM) to the Na’-independent class of these, 
apparently linked to chloride conductance, which cor- 
responds to synaptic GABA receptors [7,13,15,16]. 
We monitored only this high affinity muscimol bind- 
ing here, which behaves as a single class in its inactiva- 
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tion (fig.1). It is this class which we show as linked to 
the benzodiazepine-binding site. The evidence pre- 
sented or reviewed does not, however, exclude that 
upon experimental fractionation these sites could be 
found on different polypeptides. It does, however, 
now show that in the membrane the two activities are 
associated in one functional structure, and this has a 
molecular mass of 2 17 000 Mr. 
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